Population-based epidemiology of Escherichia coli ST1193 causing blood stream infections in a centralized Canadian region

Author(s):  
Gisele Peirano ◽  
Yasufumi Matsumara ◽  
Diego Nobrega ◽  
Rebekah DeVinney ◽  
Johann Pitout
2012 ◽  
Vol 6 (1) ◽  
pp. 3-9
Author(s):  
Suzan I. Majeed ◽  
Khawlah J. Khalaf ◽  
Mazin K. Ameen

Data regarding the incidence, etiology and outcome of Bacteraemia taken from AL-Kindi hospital were collected, and compared the situation between the three years: 2007, 2008, 2009. A total number of blood samples was (505), from this number only (70) (13.8%) is positive. The rate of positivity was significant greater in 2009 (17.7%) than 2008 (11.8%) and 2007 (9.1%). The calculated incidence of significant episodes of bacteraemia was 12.6% .The five most commonly isolated microorganisms were: Salmonella typhi30(46.8%), Staphylococcus aureus 12 (18.7%), Escherichia coli 10 (15.6%),Klebsiella 4(6.2%) and Enterobacter sp.3(4.6%) varied throughout this period, significant increase was noted in 2009. The acquisition of blood stream infections was nosocomial in 8.5% of cases.60% of Salmonella typhi were Amoxicillin resistant. Also Staph.aureus isolates, 58%were resistant to Amoxicillin and Erythromycin. Cephalexin-resistant E.coli in70% of the isolates and Gentamycin-resistant Klebsiella occurred in 75% of the isolates. The incidence of BSI did not differ significantly from other reported studies.


2018 ◽  
Vol 101 (1) ◽  
pp. 21-27 ◽  
Author(s):  
Rasmus Sørrig ◽  
Tobias W. Klausen ◽  
Morten Salomo ◽  
Annette Vangsted ◽  
Peter Gimsing

2013 ◽  
Vol 131 (2) ◽  
pp. AB152
Author(s):  
Hyeon Jong Jong Yang ◽  
Duk Won Bang ◽  
Eell Ryoo ◽  
Larry Baddour ◽  
Majdi Al-Hasan ◽  
...  

2020 ◽  
Vol 19 (6) ◽  
pp. 1285-1293
Author(s):  
Lorina I. Badger-Emeka ◽  
Zainab Yaseen Al-Jaziri ◽  
Naheed Kausar ◽  
Nora Ahmad Al-Muhainy ◽  
Edric Estrella

Purpose: To investigate the antimicrobial susceptibility and extended spectrum β-lactamase (ESBL) production by clinical isolates of Escherichia coli (ESBL-EC) and Klebsiella species (ESBL-KP) associated with blood stream infections (BSIs).Methods: Bacteria isolation and identification were carried out using basic bacteriological and biochemical techniques. Antimicrobial susceptibility test was performed according to the guidelines of the Clinical Laboratory Standard Institute (CLSI). Vitek 2 Compact automated system was used toconfirm the identifications (ID) and antimicrobial susceptibility test (AST). The ESBL produced by E. coli and K. pneumoniae isolates were  phenotypically characterised using Modified Double Disc Synergy Test (MDDST), as recommended by CLSI.Results: All (100 %) isolates were sensitive to imipenem and meropenem, while susceptibility to other antibiotics varied. ESBL genotypes, viz, blaTEM, blaSHV and blaCTX were encountered in the BSIs. For ESBL-EC, TEM, SHV and CTX producers accounted for 33, 16.67 and 58.3 %,  respectively, while 75, 91.7 and 100 % of ESBL-KP were TEM, SHV and CTX producers, respectively. In ESBL-KP, 67 % coexisted with all three genotypes (blaTEM, blaSHV, and blaCTX, while 8.3 % of ESBL-EC coexisted with the three encoding genes (CTX, SHV and TEM).Conclusion: ESBL E. coli and K. pneumoniae associated with BSI have been identified as TEM, SHV and CXT producers, with more ESBL-KP coexisting with all three than ESBL-EC. Keywords: β-Lactamases, Genes, Klebsiella pneumoniae, Escherichia coli


2016 ◽  
Author(s):  
Pierre Nouvellet ◽  
J.V. Robotham ◽  
N.R. Naylor ◽  
N. Woodford ◽  
Neil M. Ferguson

AbstractThe rising threat of antibiotic resistance in Europe and beyond is of increasing concern and is prompting renewed effort to better understand and mitigate their impact. Escherichia Coli blood stream infections are a more major concern in Europe given their incidence and severe associated outcomes. Additionally the level of 3rd generation cephalosporins and carbapenems resistance among those bacteraemia has significantly increased, limiting available treatment options. We estimated the current burden associated with E. coli blood stream infections in Europe at 17,000 (95%CI [8,000; 30,000]) excess deaths and 960,000 (95%CI [600,000; 1,450,000]) extra hospital bed days. From those, the contribution due to 3rd generation cephalosporins and carbapenems resistant strains reached 6,000 (95%CI [2,000; 12,000]) excess deaths, and 200,000 (95%CI [76,000; 420,000]) extra hospital bed stay. In the worst case scenario, we estimated the burden of E. coli blood stream infection in 2026 could increase over 4-fold, mostly resulting from an increase in the level of resistance rather than an increase in the incidence of blood stream infections. Finally, we estimated that the impact of combined novel diagnostics and treatments could substantially reduce the excess mortality by 18.5% to 55.5%, and length of stay by 13.2% to 75.6%.


PLoS ONE ◽  
2020 ◽  
Vol 15 (2) ◽  
pp. e0220428 ◽  
Author(s):  
Naveen Kumar Devanga Ragupathi ◽  
Balaji Veeraraghavan ◽  
Dhiviya Prabaa Muthuirulandi Sethuvel ◽  
Shalini Anandan ◽  
Karthick Vasudevan ◽  
...  

2012 ◽  
Vol 129 (2) ◽  
pp. AB165
Author(s):  
H.J. Yang ◽  
J. Lee ◽  
L.M. Baddour ◽  
M.N. Al-Hasan ◽  
B.P. Yawn ◽  
...  

2020 ◽  
Vol 101 ◽  
pp. 114
Author(s):  
N.K. Devanga Ragupathi ◽  
K. Vasudevan ◽  
D.P. Muthuirulandi Sethuvel ◽  
B. Veeraraghavan

2013 ◽  
Vol 13 (S1) ◽  
Author(s):  
Adriana Hristea ◽  
Raluca Jipa ◽  
Ioana D Olaru ◽  
Cristina Popescu ◽  
Victoria Aramă ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document